A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.
Primary Sponsor
NCIC CTG
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
180
Trial Chairperson
International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua
Trial Contact
ymurray@ctg.queensu.ca
Clinical Trial Registration
Related Post
18 September, 2024
TOPGEAR trial findings published in NEJM
18 September 2024: We’re thrilled to announce the release
11 September, 2024
Putting radiation medicine research on the world stage: 2024 ASM a resounding success
11 September 2024: Our 2024 Annual Scientific Meeting was
